Applied Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
11.50
|
|
Average Rating
|
4.60
|
|
# Strong Buys
|
4
|
|
# Buys
|
0
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.48
|
-0.40
|
0.08
|
16.67%
|
|
2022-06-30
|
-0.78
|
-0.96
|
-0.18
|
-23.08%
|
|
2022-03-31
|
-0.83
|
-0.88
|
-0.05
|
-6.02%
|
|
2021-12-31
|
-1.25
|
-1.04
|
0.21
|
16.80%
|
|
2021-09-30
|
-1.16
|
-1.09
|
0.07
|
6.03%
|
|
2021-06-30
|
-1.13
|
-0.99
|
0.14
|
12.39%
|
|
2021-03-31
|
-1.01
|
-1.00
|
0.01
|
0.99%
|
|
2020-12-31
|
-1.25
|
-1.06
|
0.19
|
15.20%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.24
|
|
2021-12-31
|
-4.12
|
|
2020-12-31
|
-4.25
|
|
2019-12-31
|
-4.38
|